You have 9 free searches left this month | for more free features.

PLA

Showing 1 - 25 of 1,990

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

PLA2R-IgG4 Detection Kit

Enrolling by invitation
  • Membranous Nephropathy - PLA2R Induced
  • Kidney Diseases-except Membranous Nephropathy
    • Hangzhou, China
      ZhejiangBiostar
    May 6, 2023

    Carotid Plaque Length and Cardiovascular Outcomes

    Active, not recruiting
    • Coronary Artery Disease
    • Carotid Plaque
      • Wuxi, Jiangsu, China
      • +4 more
      Apr 25, 2023

      Hemophilia B Trial in Beijing (Sodium valproate extended-release tablets)

      Recruiting
      • Hemophilia B
      • Sodium valproate extended-release tablets
      • Beijing, China
        PLA General Hospital
      Jun 17, 2023

      T-Dxd in Treatment of HER2-positive BCBM After Prior Pyrotinib

      Recruiting
      • Breast Cancer
      • Beijing, Beijing, China
      • +1 more
      Nov 13, 2023

      Prostate Cancer Trial in Beijing (CART-PSMA cells)

      Recruiting
      • Prostate Cancer
      • CART-PSMA cells
      • Beijing, China
        Chinese PLA General Hospital
      Dec 12, 2022

      Recurrent Glioblastoma Multiforme Trial in Beijing (SNC-109 CAR-T Cells)

      Recruiting
      • Recurrent Glioblastoma Multiforme
      • SNC-109 CAR-T Cells
      • Beijing, China
        Chinese PLA General Hospital
      May 11, 2023

      Transfusion Dependent Beta-Thalassaemia Trial in Nanning (ET-01)

      Recruiting
      • Transfusion Dependent Beta-Thalassaemia
      • ET-01
      • Nanning, Guangxi, China
        PLA 923 Hospital
      Mar 2, 2023

      Tetraplegia Trial in Beijing (NEO)

      Not yet recruiting
      • Tetraplegia
      • NEO
      • Beijing, Beijing, China
      • +2 more
      Jun 16, 2023

      No.253 Lymph Node Metastasis Patterns in Left-Sided Colon and

      Recruiting
      • Colorectal Cancer
      • Lymph Node Metastasis
      • Laparoscopic colorectal surgery
      • Beijing, Beijing, China
      • +3 more
      Nov 16, 2023

      Aging Problems Trial in Seongnam (needless laser injector (Mirajet), needle injection)

      Completed
      • Aging Problems
      • needless laser injector (Mirajet)
      • needle injection
      • Seongnam, Korea, Republic of
        Seoul National University Bundang Hospital
      Jan 12, 2023

      Immune Thrombocytopenia Trial in Beijing (Baricitinib 2 MG, Dexamethasone)

      Recruiting
      • Immune Thrombocytopenia
      • Beijing, China
      • +9 more
      Jul 11, 2023

      Immune Thrombocytopenia Trial in Beijing (Baricitinib 2 MG [Olumiant], Danazol)

      Not yet recruiting
      • Immune Thrombocytopenia
      • Beijing, Beijing, China
      • +9 more
      May 2, 2023

      Skin Lesion, Nevus Trial (DermTech PLA noninvasive adhesive biopsy)

      Not yet recruiting
      • Skin Lesion
      • Nevus
      • DermTech PLA noninvasive adhesive biopsy
      • (no location specified)
      Jun 13, 2022

      Hemorrhoids Trial (Mesoglycan, Placebo)

      Not yet recruiting
      • Hemorrhoids
      • (no location specified)
      Oct 27, 2023

      Invasive Mechanical Ventilation ARDS Trial in Beijing

      Recruiting
      • Invasive Mechanical Ventilation ARDS
        • Beijing, Beijing, China
          Department of Pulmonary and Critical Care Medicine, Chinese PLA
        Jun 27, 2023

        Lung Cancer, Bronchial Cancer, Non Small Cell Lung Cancer Trial in Anqing (Recombinant oncolytic herpes simplex virus type 1

        Recruiting
        • Lung Cancer
        • +11 more
        • Recombinant oncolytic herpes simplex virus type 1 (R130)
        • Anqing, Anhui, China
          The PLA Navy Anqing Hospital
        May 23, 2023

        Male Infertility Trial in Hamilton (Active multi-ingredient supplement (Fertility Enhancer, FE), Inactive (Placebo; PLA))

        Not yet recruiting
        • Male Infertility
        • Active multi-ingredient supplement (Fertility Enhancer, FE)
        • Inactive placebo (Placebo; PLA)
        • Hamilton, Ontario, Canada
          Mark Tarnopololsky
        Oct 23, 2023

        Advanced HCC Trial in Beijing (KN046 (PD-L1/CTLA4 BsAb), Ningetinib Tosylate(multi-target TKI))

        Terminated
        • Advanced HCC
        • KN046 (PD-L1/CTLA4 BsAb)
        • Ningetinib Tosylate(multi-target TKI)
        • Beijing, Beijing, China
          Chinese Pla General Hospital Chinese Pla Medical School
        Oct 26, 2022

        Carotid Plaque Length to Predict Cardiovascular Events

        Active, not recruiting
        • Coronary Artery Disease
          • Wuxi, Jiangsu, China
          • +4 more
          Jun 3, 2022

          Alzheimer Trial in Beijing (XTR006)

          Recruiting
          • Alzheimer Disease
          • XTR006
          • Beijing, Beijing Shi, China
            Chinese PLA General Hospital
          Nov 21, 2023

          Postoperative Complications, Morality Trial in Xi'an (In-Hospital COVID-19 Omicron Infection after surgery)

          Completed
          • Postoperative Complications
          • Morality
          • In-Hospital COVID-19 Omicron Infection after surgery
          • Xi'an, Shannxi, China
            The Second Affiliated Hospital of Air Force Medical University U
          Sep 8, 2023

          Clinical Phenotypic Characteristics of SC26A4

          Recruiting
          • Hearing Loss
          • Pendred Syndrome
            • Beijing, Beijing, China
              Chinese PLA General Hospital
            Jul 24, 2023

            Acute Myeloid Leukemia Trial in Beijing (Azacytidine;Cytarabine;Aclacinomycin;Chidamide;Venetoclax;Granulocyte

            Recruiting
            • Acute Myeloid Leukemia
            • Azacytidine;Cytarabine;Aclacinomycin;Chidamide;Venetoclax;Granulocyte colony-stimulating factor
            • "3+7"
            • Beijing, Beijing, China
              Chinese PLA General Hospital
            Sep 29, 2023

            Thrombus Imaging and Treatment Analytics in Neurology

            Not yet recruiting
            • Thrombus, Brain
            • Thrombosis
            • thrombus imaging appearance
            • Beijing, Beijing, China
              Chinese PLA General Hospital
            Dec 15, 2022

            Peripherally Inserted Central Catheter Trial in Beijing (Arrowga+rd Blue Advance Protection PICC Placement, Sham Comparator PICC

            Recruiting
            • Peripherally Inserted Central Catheter
            • Arrowga+rd Blue Advance Protection PICC Placement
            • Sham Comparator PICC placement
            • Beijing, Doncheng District, China
            • +4 more
            Jan 20, 2023